MoneyWorks4Me

Jenburkt Pharmaceuticals informs about unaudited financial results

30 Jul 2019 Evaluate

Jenburkt Pharmaceuticals has informed that the Board of Directors of the Company has approved the unaudited financial results for the quarter ended 30th June, 2019.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..